Recital (1) · Commission Implementing Regulation (EU) 2024/2781

(1)Commission Implementing Regulation (EU) No 993/2011^note approved the active substance 8-hydroxyquinoline until 31 December 2021. Commission Implementing Regulation (EU) No 891/2014^note approved the active substance aminopyralid until 31 December 2024. Commission Implementing Regulation (EU) No 703/2011^note approved the active substance azoxystrobin until 31 December 2021. Commission Implementing Regulation (EU) No 373/2013^note approved the active substance Candida oleophila strain O until 30 September 2023. Commission Implementing Regulation (EU) No 1199/2013^note approved the active substance chlorantraniliprole until 30 April 2024. Commission Implementing Regulation (EU) No 736/2011^note approved the active substance fluroxypyr until 31 December 2021. Commission Implementing Regulation (EU) No 705/2011^note approved the active substance imazalil until 31 December 2021. Commission Implementing Regulation (EU) No 810/2011^note approved the active substance kresoxim-methyl until 31 December 2021. Commission Implementing Regulation (EU) No 890/2014^note approved the active substance metobromuron until 31 December 2024. Commission Implementing Regulation (EU) No 798/2011^note approved the active substance oxyfluorfen until 31 December 2021. Commission Implementing Regulation (EU) No 378/2013^note approved the active substance Paecilomyces fumosoroseus strain FE 9901 until 30 September 2023. Commission Implementing Regulation (EU) No 800/2011^note approved the active substance tefluthrin until 31 December 2021 and Commission Implementing Regulation (EU) No 820/2011^note approved the active substance terbuthylazine until 31 December 2021.